Related Experiment Video
Updated: Jun 15, 2025

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
A Case of Acute Intoxication from Sublingually Administering a Liquid Inhalation Product Containing a Marijuana
Yuri Iketani1, Seiji Morita, Tomoatsu Tsuji
1Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. e133006g@gmail.com.
Hexahydrocannabiphorol (HHCP) inhalation liquid caused acute poisoning in a young man, leading to convulsions and hallucinations. This case highlights potential health risks associated with HHCP, even after its regulation in Japan.
Area of Science:
- Toxicology
- Pharmacology
Background:
- Hexahydrocannabiphorol (HHCP) is a cannabinoid with limited clinical data.
- HHCP was legally available via mail order in Japan prior to January 2024.
Observation:
- A 20-year-old male presented with dysarthria, vomiting, convulsions, agitation, and visual hallucinations after sublingual HHCP use.
- Initial blood tests revealed acidosis and elevated lactic acid levels.
Findings:
- The patient was diagnosed with acute HHCP poisoning and treated with intravenous fluids.
- Recovery was observed over five days, with improvements in communication and ability to eat.
Implications:
- This case demonstrates that HHCP can cause significant adverse health effects.
- Healthcare providers and the public should remain aware of potential risks from HHCP, despite recent regulatory changes in Japan.
More Related Videos
Related Concept Videos
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Inhalational Anesthetics: Overview
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Parenteral Anesthetics: Overview

